X
Please Wait
Applying Filters...
01 OXALIPLATIN (3)
02 Oxaliplatin (1)
01 AqVida GmbH (1)
02 SANOFI AVENTIS US (3)
01 INJECTABLE;INTRAVENOUS (3)
02 SOLUTION FOR INFUSION (1)
01 100MG/20ML (5MG/ML) (1)
02 200MG/40ML (1)
03 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
04 50MG/10ML (5MG/ML) (1)
01 Germany (1)
02 USA (3)
CPhI Japan
Not Confirmed
Contact SupplierCPhI Japan
Not Confirmed
Contact SupplierCPhI Japan
Not Confirmed
Contact Supplier
19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is OXALIPLATIN, with a corresponding application number 21759 and regulatory information .
proudly manufactured in the
approval since 2005-01-31
Sanofi's ELOXATIN INJECTABLE;INTRAVENOUS, medication with 100MG/20ML (5MG/ML) of OXALIPLATIN.
18
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is OXALIPLATIN, with a corresponding application number 21759 and regulatory information .
proudly manufactured in the
approval since 2006-11-17
Sanofi's ELOXATIN INJECTABLE;INTRAVENOUS, medication with 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of OXALIPLATIN.
17
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is OXALIPLATIN, with a corresponding application number 21759 and regulatory information .
proudly manufactured in the
approval since 2005-01-31
Sanofi's ELOXATIN INJECTABLE;INTRAVENOUS, medication with 50MG/10ML (5MG/ML) of OXALIPLATIN.
16
AqVida GmbH, based in Germany, is a pharmaceutical company.
One of their notable products is Oxaliplatin, with a corresponding application number 21759 and regulatory information .
proudly manufactured in the
AqVida GmbH's SOLUTION FOR INFUSION, medication with 200MG/40ML of Oxaliplatin.
Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
